| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680370 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2017 | 8 Pages |
Abstract
We found a good diagnostic accuracy for higher levels of CSF NfL and YKL40 and reduced p-tau/tau ratio in distinguishing bvFTD from PSY. We advocate the use of these CSF biomarkers as potential additional tools to neuroimaging in the diagnosis of bvFTD versus PSY.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Everard G.B. Vijverberg, Annemiek Dols, Welmoed A. Krudop, Marta Del Campo Milan, Cora J. Kerssens, Flora Gossink, Niels D. Prins, Max L. Stek, Philip Scheltens, Charlotte E. Teunissen, Yolande A.L. Pijnenburg,